As researchers push for a type 1 diabetes cure, Sana Biotechnology has provided a nudge forward with new, if limited, ...
Sana Biotechnology has shared early data for its investigational allogeneic cell therapy being studied in one patient with ...
In a small randomized trial, people who took capsules containing donated gut microbiomes experienced fewer gastrointestinal ...
A completely new way of treating type 1 diabetes is being tested at Uppsala University Hospital. Patients are being offered ...
For years, attempts have been made to cure type 1 diabetes, in which sufferers are dependent on insulin injections as soon as ...
People often let chronic conditions such as high blood pressure and diabetes go for a long time without treatment. Here’s why ...
Samantha Semenkow, an analyst from Citi, maintained the Buy rating on Sana Biotechnology (SANA – Research Report). The associated price target ...
Sana Biotechnology’s hypoimmune platform enables it to make a series of genetic modifications to cells, rendering the cells ...
In the first study of its kind, researchers reported that fecal microbiota transplantation was a safe and beneficial approach ...
Sana Biotechnology, Inc. shares surge as a breakthrough in diabetes therapy sparks investor interest. Click for my updated ...
Verywell Health on MSN7d
What Are the Different Types of Diabetes?Diabetes mellitus, more commonly known as diabetes, actually consists of many different types. Learn more about the ...
About the T1D Fund: A Breakthrough T1D Venture, LLC The T1D Fund is an impact investment fund accelerating life-changing solutions to treat, prevent, and ultimately cure type 1 diabetes (T1D).
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback